We are live on ! Find out more
FULC icon

Fulcrum Therapeutics

117 hedge funds and large institutions have $148M invested in Fulcrum Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

270% more call options, than puts

Call options by funds: $148K | Put options by funds: $40K

0.74% less ownership

Funds ownership: 95.9%95.16% (-0.74%)

2% less funds holding

Funds holding: 119117 (-2)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

30% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 44

39% less capital invested

Capital invested by funds: $243M → $148M (-$95M)

Holders
117
Holders Change
-2
Holders Change %
-1.68%
% of All Funds
1.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
31
Reduced
44
Closed
19
Calls
$148K
Puts
$40K
Net Calls
+$108K
Net Calls Change
-$5.12M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
126
Corton Capital
Ontario, Canada
-$110K -23,498 Closed
CF
127
Cantor Fitzgerald
New York
-$94K -20,000 Closed
Mariner
128
Mariner
Kansas
-$77.6K -16,516 Closed
WG
129
Winton Group
United Kingdom
-$61.1K -12,997 Closed
Belvedere Trading
130
Belvedere Trading
Illinois
-$3.56K -758 Closed
CMBA
131
C.M. Bidwell & Associates
Hawaii
-$550 -117 Closed
HWM
132
HighMark Wealth Management
Minnesota
-$470 -100 Closed
Osaic Holdings
133
Osaic Holdings
Arizona
-$447 -95 Closed
LFG
134
Larson Financial Group
Missouri
-$71 -15 Closed
Zurich Cantonal Bank
135
Zurich Cantonal Bank
Switzerland
-$14 -3 Closed
Carson Wealth (CWM LLC)
136
Carson Wealth (CWM LLC)
Nebraska
+$121 +33 +330%

FULC Hedge Fund Activity: Q1 2025 in Review

117 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q1 2025, worth a combined $148M — down 39% from $243M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of FULC and 17 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 31 added.

The largest buyer was Suvretta Capital Management, adding an estimated $6.35M. The largest seller was Morgan Stanley, cutting an estimated $4.58M.

  • 117 institutional investors held Fulcrum Therapeutics (FULC) as of Q1 2025, down from 119 in Q4 2024.
  • Funds reported $148M of Fulcrum Therapeutics stock for Q1 2025, down 39% quarter-over-quarter.
  • 17 funds opened new Fulcrum Therapeutics positions in Q1 2025 and 19 closed out, a net change of -2 holders.
  • The largest Fulcrum Therapeutics buyer in Q1 2025 was Suvretta Capital Management, an estimated $6.35M added.
  • The largest Fulcrum Therapeutics seller in Q1 2025 was Morgan Stanley, an estimated $4.58M sold.

Based on aggregated 13F filings for Q1 2025.